Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-inflammatory CD14 peptides

Anti-inflammatory CD14 peptides

US Patent 5766593 · Granted Jun 16, 1998

Estimated economic value: $28,431,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Rapamycin for the treatment of lymphangioleiomyomatosis2024
Methods and apparatus for making biological predictions using a trained multi-mo2024
Combination therapy with apilimod and glutamatergic agents2024
Rapamycin for the treatment of lymphangioleiomyomatosis2023
Reconstituted high density lipoprotein formulation and production method thereof2023
Inhalable rapamycin formulation for treating age-related conditions2023
Inhalable rapamycin formulation for the treatment of pulmonary hypertension2022
Combination therapy with apilimod and glutamatergic agents2022
Apilimod compositions and methods for using same2022
Apilimod compositions and methods for using same in the treatment of renal cance2021
Rapamycin for the treatment of lymphangioleiomyomatosis2021
Inhalable rapamycin formulation for treating age-related conditions2021